AIMS/HYPOTHESIS: Of the four exocytotic syntaxins (Syns), much is now known about the role of Syn-1A (pre-docked secretory granules [SGs]) and Syn-3 (newcomer SGs) in insulin exocytosis. Some work was reported on Syn-4's role in biphasic glucose-stimulated insulin secretion (GSIS), but its precise role in insulin SG exocytosis remains unclear. In this paper we examine this role in human beta cells. METHODS: Endogenous function of Syn-4 in human islets was assessed by knocking down its expression with lentiviral single hairpin RNA (lenti-shRNA)-RFP. Biphasic GSIS was determined by islet perifusion assay. Single-cell analysis of exocytosis of red fluorescent protein (RFP)-positive beta cells (exhibiting near-total depletion of Syn-4) was by patch clamp capacitance measurements (Cm) and total internal reflection fluorescence microscopy (TIRFM), the latter to further assess single SG behaviour. Co-immunoprecipitations were conducted on INS-1 cells to assess exocytotic complexes. RESULTS: Syn-4 knockdown (KD) of 77% in human islets caused a concomitant reduction in cognate Munc18c expression (46%) without affecting expression of other exocytotic proteins; this resulted in reduction of GSIS in the first phase (by 42%) and the second phase (by 40%). Cm of RFP-tagged Syn-4-KD beta cells showed severe inhibition in the readily releasable pool (by 71%) and mobilisation from reserve pools (by 63%). TIRFM showed that Syn-4-KD-induced inhibition of first-phase GSIS was attributed to reduction in exocytosis of both pre-docked and newcomer SGs (which undergo minimal residence or docking time at the plasma membrane before fusion). Second-phase inhibition was attributed to reduction in newcomer SGs. Stx-4 co-immunoprecipitated Munc18c, VAMP2 and VAMP8, suggesting that these exocytotic complexes may be involved in exocytosis of pre-docked and newcomer SGs. CONCLUSIONS/ INTERPRETATION: Syn-4 is involved in distinct molecular machineries that influence exocytosis of both pre-docked and newcomer SGs in a manner functionally redundant to Syn-1A and Syn-3, respectively; this underlies Syn-4's role in mediating portions of first-phase and second-phase GSIS.
AIMS/HYPOTHESIS: Of the four exocytotic syntaxins (Syns), much is now known about the role of Syn-1A (pre-docked secretory granules [SGs]) and Syn-3 (newcomer SGs) in insulin exocytosis. Some work was reported on Syn-4's role in biphasic glucose-stimulated insulin secretion (GSIS), but its precise role in insulin SG exocytosis remains unclear. In this paper we examine this role in human beta cells. METHODS: Endogenous function of Syn-4 in human islets was assessed by knocking down its expression with lentiviral single hairpin RNA (lenti-shRNA)-RFP. Biphasic GSIS was determined by islet perifusion assay. Single-cell analysis of exocytosis of red fluorescent protein (RFP)-positive beta cells (exhibiting near-total depletion of Syn-4) was by patch clamp capacitance measurements (Cm) and total internal reflection fluorescence microscopy (TIRFM), the latter to further assess single SG behaviour. Co-immunoprecipitations were conducted on INS-1 cells to assess exocytotic complexes. RESULTS:Syn-4 knockdown (KD) of 77% in human islets caused a concomitant reduction in cognate Munc18c expression (46%) without affecting expression of other exocytotic proteins; this resulted in reduction of GSIS in the first phase (by 42%) and the second phase (by 40%). Cm of RFP-tagged Syn-4-KD beta cells showed severe inhibition in the readily releasable pool (by 71%) and mobilisation from reserve pools (by 63%). TIRFM showed that Syn-4-KD-induced inhibition of first-phase GSIS was attributed to reduction in exocytosis of both pre-docked and newcomer SGs (which undergo minimal residence or docking time at the plasma membrane before fusion). Second-phase inhibition was attributed to reduction in newcomer SGs. Stx-4 co-immunoprecipitated Munc18c, VAMP2 and VAMP8, suggesting that these exocytotic complexes may be involved in exocytosis of pre-docked and newcomer SGs. CONCLUSIONS/ INTERPRETATION:Syn-4 is involved in distinct molecular machineries that influence exocytosis of both pre-docked and newcomer SGs in a manner functionally redundant to Syn-1A and Syn-3, respectively; this underlies Syn-4's role in mediating portions of first-phase and second-phase GSIS.
Authors: Rory R Duncan; Jennifer Greaves; Ulrich K Wiegand; Ioulia Matskevich; Georg Bodammer; David K Apps; Michael J Shipston; Robert H Chow Journal: Nature Date: 2003-03-13 Impact factor: 49.962
Authors: Catherine F Latham; Jamie A Lopez; Shu-Hong Hu; Christine L Gee; Elizabeth Westbury; Duncan H Blair; Chris J Armishaw; Paul F Alewood; Nia J Bryant; David E James; Jennifer L Martin Journal: Traffic Date: 2006-08-10 Impact factor: 6.215
Authors: C Yang; K J Coker; J K Kim; S Mora; D C Thurmond; A C Davis; B Yang; R A Williamson; G I Shulman; J E Pessin Journal: J Clin Invest Date: 2001-05 Impact factor: 14.808
Authors: Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Quan Zhang; Jovita Karanauskaite; Chris Partridge; Paul R Johnson; Patrik Rorsman Journal: Diabetes Date: 2008-04-04 Impact factor: 9.461
Authors: Patrick P L Lam; Mitsuyo Ohno; Subhankar Dolai; Yu He; Tairan Qin; Tao Liang; Dan Zhu; Youhou Kang; Yunfeng Liu; Maria Kauppi; Li Xie; Wilson C Y Wan; Na-Rhum Bin; Shuzo Sugita; Vesa M Olkkonen; Noriko Takahashi; Haruo Kasai; Herbert Y Gaisano Journal: Diabetes Date: 2013-02-19 Impact factor: 9.461
Authors: Tao Liang; Tairan Qin; Fei Kang; Youhou Kang; Li Xie; Dan Zhu; Subhankar Dolai; Dafna Greitzer-Antes; Robert K Baker; Daorong Feng; Eva Tuduri; Claes-Goran Ostenson; Timothy J Kieffer; Kate Banks; Jeffrey E Pessin; Herbert Y Gaisano Journal: JCI Insight Date: 2020-02-13
Authors: Dan Zhu; Li Xie; Youhou Kang; Subhankar Dolai; Jakob Bondo Hansen; Tairan Qin; Huanli Xie; Tao Liang; Deborah C Rubin; Lucy Osborne; Herbert Y Gaisano Journal: Diabetes Date: 2017-01-23 Impact factor: 9.461
Authors: Sarah E Wheeler; Holly M Stacey; Yasaman Nahaei; Stephen J Hale; Alexandre B Hardy; Frank Reimann; Fiona M Gribble; Pierre Larraufie; Herbert Y Gaisano; Patricia L Brubaker Journal: Diabetes Date: 2017-06-08 Impact factor: 9.461